£70.75

Oncogenesis of Lymphoma

Price data last checked 27 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£71 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days · 64 data points (no recent data)

Historical
Generating forecast…
£70.75 £67.21 £68.63 £70.04 £71.46 £72.87 £74.29 25 June 2026 10 July 2026 26 July 2026 11 August 2026 27 August 2026

Price Distribution

Price distribution over 64 days • 1 price levels

Days at Price
64 days 0 16 32 48 64 £71 Days at Price

Price Analysis

Most common price: £71 (64 days, 100.0%)

Price range: £71 - £71

Price levels: 1 different prices over 64 days

Description

This Special Issue on the topic of the oncogenesis of lymphoma focuses on three major areas of research: viral oncogenesis, molecular mechanisms of transformation, and putative microbial drivers. The section on viral oncogenesis highlights the role of the Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) in lymphoid malignancies. Contributions discuss EBV-positive classic Hodgkin lymphoma in immunodeficient hosts, the interplay between EBV and MYC in Burkitt lymphoma, and KSHV-mediated signaling alterations in primary effusion lymphoma and multicentric Castleman disease. Another review addresses lymphoproliferative disorders in people living with HIV, examining clinical heterogeneity and emerging immunotherapeutic strategies. The molecular transformation section examines the progression of indolent B-cell malignancies to aggressive lymphomas, emphasizing genetic lesions and immune dysregulation. Additional articles explore the relevance of TNF family receptors in classic Hodgkin lymphoma, the impact of c-MYC overexpression and IGH rearrangements in chronic lymphocytic leukemia, and integrated genomic-TCR profiling to refine diagnosis and prognosis in early mycosis fungoides. Finally, studies on putative microbial drivers investigate the contribution of skin dysbiosis-particularly toxin-producing Staphylococcus aureus-to T-cell activation in mycosis fungoides, and microbiome features in breast implant-associated anaplastic large cell lymphoma, supporting multifactorial rather than pathogen-specific etiologies.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
12 February 2026
Listed Since
10 March 2026

Barcode

No barcode data available

Similar Products You Might Like

PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
88% match

PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer

£89.51 08 Aug 2026
Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles
88% match

Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles

£64.27 18 Aug 2026
Emerging Antibody Engineering Strategies and Applications for Immunotherapy of Cancer
86% match

Emerging Antibody Engineering Strategies and Applications for Immunotherapy of Cancer

£62.50 18 Aug 2026
Radiopharmaceuticals
86% match

Radiopharmaceuticals

£87.68 08 Aug 2026
Germ Line Mutations Associated Leukemia
86% match

Germ Line Mutations Associated Leukemia

IntechOpen

£100.00 12 Aug 2026
Novel Anticancer Strategies (Volume II)
86% match

Novel Anticancer Strategies (Volume II)

£121.53 18 Aug 2026
Indolent Lymphomas (Hematologic Malignancies)
86% match

Indolent Lymphomas (Hematologic Malignancies)

Springer

£103.27 12 Aug 2026
Hydrothermal Carbonization
86% match

Hydrothermal Carbonization

£51.92 18 Aug 2026
Cancer
85% match

Cancer

£160.28 09 Aug 2026
Plant Genomics
85% match

Plant Genomics

£94.76 08 Aug 2026
Lignocellulosic Biomass II
85% match

Lignocellulosic Biomass II

£71.62 18 Aug 2026
Treatment of Leukemia and Lymphoma
85% match

Treatment of Leukemia and Lymphoma

Academic Press

£175.00 05 Aug 2026
Monoclonal Antibodies in Oncology
85% match

Monoclonal Antibodies in Oncology

£90.00 14 Aug 2026
Ductal Carcinoma in Situ of the Breast
85% match

Ductal Carcinoma in Situ of the Breast

Springer

£95.74 05 Aug 2026
Management of Oral Cancers
85% match

Management of Oral Cancers

Springer

£88.21 08 Aug 2026
Synthesis and Characterization of Biomedical Materials
85% match

Synthesis and Characterization of Biomedical Materials

£75.38 18 Aug 2026
Lymphoma: Methods and Protocols (Methods in Molecular Biology, 2865)
85% match

Lymphoma: Methods and Protocols (Methods in Molecular Biology, 2865)

Humana

£148.69 07 Aug 2026
Vegetable Genomics and Breeding Research
85% match

Vegetable Genomics and Breeding Research

£62.50 18 Aug 2026
Immunotherapy for Gastrointestinal Cancer
84% match

Immunotherapy for Gastrointestinal Cancer

Springer

£73.10 04 Aug 2026
Neurodegenerative Disease: From Molecular Basis to Therapy
84% match

Neurodegenerative Disease: From Molecular Basis to Therapy

£77.50 20 Aug 2026
Orthopedics and Trauma in Children
84% match

Orthopedics and Trauma in Children

£64.27 18 Aug 2026
Precision Molecular Pathology of Aggressive B-Cell Lymphomas (Molecular Pathology Library)
84% match

Precision Molecular Pathology of Aggressive B-Cell Lymphomas (Molecular Pathology Library)

Springer

£95.74 04 Aug 2026
Advances in Hyperspectral Data Exploitation
84% match

Advances in Hyperspectral Data Exploitation

£80.04 06 Aug 2026
Brain-Targeted Drug Delivery
84% match

Brain-Targeted Drug Delivery

£57.68 18 Aug 2026